KATHERINE HAVANIDIS: Open Payments
NPI 1205336419 · BOSTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$198 in 5 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $23 · 2025 $198
Food & beverage: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $178 |
| Ferring Pharmaceuticals Inc. | 1 | $20 |
Products named: RYBREVANT, ERLEADA, ADSTILADRIN.
Industry payments across MA — which companies pay providers there.
